Pacific Center for Financial Services
Position in BMY — Bristol Myers Squibb Co
CIK 1698222
SAN RAMON, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$158,858
-$8,354 QoQ
Shares Held
2,757
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,186
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacific Center for Financial Services holds $1,504,810 across 13 Drug Manufacturers - General names. BMY ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 3 | ABBV |
AbbVie Inc.
|
935 | $235,283 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
2,757 | $158,858 | |
| 5 | PFE |
Pfizer Inc
|
4,775 | $114,982 | |
| 6 | AMGN |
Amgen Inc
|
264 | $95,599 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
612 | $77,320 | |
| 8 | AZN |
Astrazeneca PLC
|
175 | $33,183 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,858 | 2,757 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $167,212 | 2,757 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $148,712 | 2,757 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $124,340 | 2,757 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $127,621 | 2,757 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $168,149 | 2,757 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $155,935 | 2,757 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $142,647 | 2,757 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $114,498 | 2,757 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $149,512 | 2,757 | Shares | Sole | 2024-05-20 | |
| 2023-12-31 | $141,461 | 2,757 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $160,016 | 2,757 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $176,310 | 2,757 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $191,087 | 2,757 | Shares | Sole | 2023-05-16 | |
| 2022-09-30 | $195,995 | 2,757 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $212,289 | 2,757 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $201,343 | 2,757 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $172,210 | 2,762 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $163,427 | 2,762 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $184,556 | 2,762 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $174,365 | 2,762 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $171,326 | 2,762 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $132,336 | 2,195 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $129,066 | 2,195 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $122,349 | 2,195 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||